Company Filing History:
Years Active: 2013-2025
Title: John Monteith Lincecum: Innovator in CD40L-Related Treatments
Introduction
John Monteith Lincecum is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of medicine, particularly in the development of treatments related to CD40L-associated diseases. With a total of 10 patents to his name, Lincecum's work has the potential to impact many lives.
Latest Patents
Lincecum's latest patents include innovative anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders. These anti-human CD40L antibodies are engineered to lack the ability to activate platelets, providing a new avenue for treating patients suffering from CD40L-associated diseases. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Lincecum has worked with prominent organizations such as ALS Therapy Development Institute and Biogen MA Inc. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Lincecum has collaborated with notable individuals in his field, including Steven N. Perrin and Alan Gill. These partnerships have further enhanced his research and development efforts, leading to significant advancements in the treatment of CD40L-related conditions.
Conclusion
John Monteith Lincecum is a distinguished inventor whose work in the field of CD40L-related treatments showcases his dedication to medical innovation. His contributions through patents and collaborations highlight the importance of research in improving healthcare solutions.